Cargando…

Is It Useful to Administer Probiotics Together With Proton Pump Inhibitors in Children With Gastroesophageal Reflux?

BACKGROUND/AIMS: Gastroesophageal reflux disease (GERD) is a frequent condition diagnosed in children and treated with proton pump inhibitors (PPI). Long-term PPI administration can alter intestinal bacterial population by suppressing the gastric acid barrier and may cause diarrhea. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Belei, Oana, Olariu, Laura, Dobrescu, Andreea, Marcovici, Tamara, Marginean, Otilia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Neurogastroenterology and Motility 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753903/ https://www.ncbi.nlm.nih.gov/pubmed/29291607 http://dx.doi.org/10.5056/jnm17059

Ejemplares similares

Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux disease.
por: Kuipers, E. J., et al.
Publicado: (1999)

Histologic recovery among children with celiac disease on a gluten-free diet. A long-term follow-up single-center experience
por: Belei, Oana, et al.
Publicado: (2017)

Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions
por: Mermelstein, Joseph, et al.
Publicado: (2018)

Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease
por: Shi, Yi-Chao, et al.
Publicado: (2019)

Comparison of Gastroesophageal Reflux Disease Symptoms and Proton Pump Inhibitor Response Using Gastroesophageal Reflux Disease Impact Scale Questionnaire
por: Jo, So Young, et al.
Publicado: (2013)

Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease
por: Tariq, Muhammad Ali, et al.
Publicado: (2022)

Proton pump inhibitors induced fungal dysbiosis in patients with gastroesophageal reflux disease
por: Shi, Yichao, et al.
Publicado: (2023)

Role of Acid and Weakly Acidic Reflux in Gastroesophageal Reflux Disease Off Proton Pump Inhibitor Therapy
por: Sung, Hea Jung, et al.
Publicado: (2012)

Complete Resolution of Pseudomalignant Erosion in a Reflux Gastroesophageal Polyp with Proton Pump Inhibitor
por: Nakajima, Takahiko, et al.
Publicado: (2015)

Predictive Factors of Response to Proton Pump Inhibitors in Korean Patients With Gastroesophageal Reflux Disease
por: Kim, Sung Eun, et al.
Publicado: (2015)

Additional Mosapride to Proton Pump Inhibitor for Gastroesophageal Reflux Disease: A Meta-Analysis
por: Nishizawa, Toshihiro, et al.
Publicado: (2020)

Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease
por: Niikura, Ryota, et al.
Publicado: (2018)

Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
por: de Sá, Cláudia Cristina, et al.
Publicado: (2011)

Does Helicobacter pylori eradication or proton pump inhibitor use benefit gastroesophageal reflux disease?
por: Sakin, Yusuf Serdar, et al.
Publicado: (2015)

Putting Out the Fire: The Relationship of Pharmacogenetics and Proton Pump Inhibitors for the Treatment of Gastroesophageal Reflux Disease
por: Zheng, Connor L, et al.
Publicado: (2018)

Can Esophageal Baseline Impedance Predict Proton Pump Inhibitor Response in Gastroesophageal Reflux Disease?
por: Jung, Kyoungwon, et al.
Publicado: (2018)

Is the Diagnostic Trial with Proton Pump Inhibitors Reasonable for School Age Children with Gastroesophageal Reflux Symptoms?
por: Yang, Jaeeun, et al.
Publicado: (2019)

Effect of a Preoperative Proton Pump Inhibitor and Gastroesophageal Reflux Disease on Postoperative Nausea and Vomiting
por: Kwon, Young Suk, et al.
Publicado: (2020)

Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease
por: Gotoh, Yasuhiko, et al.
Publicado: (2020)

Anti-reflux Surgery Versus Proton Pump Inhibitors for Severe Gastroesophageal Reflux Disease: A Cost-Effectiveness Study in Korea
por: Park, Susan, et al.
Publicado: (2020)

Efficacy of proton pump inhibitors and H2 blocker in the treatment of symptomatic gastroesophageal reflux disease in infants
por: Azizollahi, Hamid Reza, et al.
Publicado: (2016)

Phenotypes of Jackhammer esophagus in patients with typical symptoms of gastroesophageal reflux disease responsive to proton pump inhibitors
por: Kristo, Ivan, et al.
Publicado: (2018)

Effects of rikkunshito on quality of life in patients with gastroesophageal reflux disease refractory to proton pump inhibitor therapy
por: Kawai, Takashi, et al.
Publicado: (2017)

Protective Effect of Proton Pump Inhibitor for Survival in Patients with Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis
por: Lee, Chang Min, et al.
Publicado: (2016)

Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?
por: Fossmark, Reidar, et al.
Publicado: (2023)

Anti-reflux mucosal ablation (ARMA) as a new treatment for gastroesophageal reflux refractory to proton pump inhibitors: a pilot study
por: Inoue, Haruhiro, et al.
Publicado: (2020)

Randomized Controlled Trial of Anti-reflux Mucosectomy Versus Radiofrequency Energy Delivery for Proton Pump Inhibitor-refractory Gastroesophageal Reflux Disease
por: Wang, Yan, et al.
Publicado: (2023)

Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole
por: Mermelstein, Joseph, et al.
Publicado: (2016)

The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux—A Prospective Longitudinal Interventional Study
por: Castellani, Christoph, et al.
Publicado: (2017)

Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy
por: Kawara, Fumiaki, et al.
Publicado: (2017)

Relationship between long-term use of proton pump inhibitor (PPI) and hypomagnesemia in patients with gastroesophageal reflux disease
por: Arj, Abbas, et al.
Publicado: (2022)

Do patients with gastroesophageal reflux disease exhibit compromised bone quality prior to proton pump inhibitor therapy?
por: Aasarød, Kristin M., et al.
Publicado: (2021)

Effects of gastroesophageal reflux disease treatment with proton pump inhibitors on the risk of acute exacerbation and pneumonia in patients with COPD
por: Kang, Jieun, et al.
Publicado: (2023)

Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors
por: Gerson, Lauren B, et al.
Publicado: (2008)

Management of laryngopharyngeal reflux with proton pump inhibitors
por: Reimer, Christina, et al.
Publicado: (2008)

Commentary: The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A Prospective Longitudinal Interventional Study
por: Drall, Kelsea M., et al.
Publicado: (2018)

Gastrointestinal symptoms associated with gastroesophageal reflux disease, and their relapses after treatment with proton pump inhibitors: A systematic review
por: Hosseini, Mousalreza, et al.
Publicado: (2017)

Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study
por: Foocharoen, Chingching, et al.
Publicado: (2020)

A Randomized Placebo-Controlled N-of-1 Trial: The Effect of Proton Pump Inhibitor in the Management of Gastroesophageal Reflux Disease
por: Sierra-Arango, Fernando, et al.
Publicado: (2019)

Profile of the Change in Depression during Proton-Pump Inhibitor Therapy in Patients with Gastroesophageal Reflux Disease: Influence of the Mucosal Break
por: Wu, Chia-Liang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9726v0t8g189htbfngt0djagi1